Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry
Abstract Immunotherapies are revolutionizing cancer care, but many patients do not achieve durable responses and immune-related adverse events are difficult to predict.Quantifying the hundreds of proteins involved in cancer immunity has the potential to provide biomarkers to monitor and predict tumor response.We previously developed robust, multipl